ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Total Non-current Assets

All assets not expected to be converted to cash within one year.

No reported Total Non-current Assets figures are available to summarize.

Total Non-current Assets history

Currency unavailable · from the balance sheet

No Total Non-current Assets data reported for this period type.

Total Non-current Assets vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Total Non-current Assets for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRMEPrime Medicine, Inc.Mar 2026$156.84M USD-4.6%+36.3%53.2%
MGTXMeiraGTx Holdings plcMar 2026$148.45M USD+3.0%-2.3%60.7%
STOKStoke Therapeutics, Inc.Mar 2026$76.6M USD+145.9%+111.0%17.3%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$28.53M USD-46.2%-14.2%11.6%
WVEWave Life Sciences Ltd.Mar 2026$22.27M USD-26.7%-20.9%3.8%
SLNSilence Therapeutics plcMar 2026$12.27M USD-20.9%+5.7%10.7%
PRQRProQR Therapeutics N.V.Mar 2026€12.06M EUR-17.9%-9.2%12.2%
RNAAtrium Therapeutics, Inc.Mar 2026$6.8M USD——2.3%
BNTCBenitec Biopharma Inc.Mar 2026$983K USD-18.0%-2.3%0.5%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-18.0%-2.3%11.6%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.